Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer ; volume:31 ; number:10 ; day:20 ; month:9 ; year:2023 ; pages:1-10 ; date:10.2023
Supportive care in cancer ; 31, Heft 10 (20.9.2023), 1-10, 10.2023
- Creator
-
Aapro, Matti S.
Chaplin, Stephen
Cornes, Paul
Howe, Sebastian
Link, Hartmut
Koptelova, Natalia
Mehl, Andrea
Palma, Mario Di
Schroader, Bridgette Kanz
Terkola, Robert
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-08043-4
- URN
-
urn:nbn:de:101:1-2024010809033516933216
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aapro, Matti S.
- Chaplin, Stephen
- Cornes, Paul
- Howe, Sebastian
- Link, Hartmut
- Koptelova, Natalia
- Mehl, Andrea
- Palma, Mario Di
- Schroader, Bridgette Kanz
- Terkola, Robert
- SpringerLink (Online service)
Other Objects (12)
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Role of granulocyte colony-stimulating factor in infection and inflammation
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Role of granulocyte colony-stimulating factor in infection and inflammation
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?